New aspect of the research on limb-girdle muscular dystrophy 2A: A molecular biologic and biochemical approach to pathology

Trends in Cardiovascular Medicine

Volumn 9, Issue 5, 1999, Pages 114-118

  Ono, Yasuko ^a   Sorimachi, Hiroyuki ^a,b   Suzuki, Koichi ^a  

^a Dept Molec Biol Inst Molec C   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CYTOSKELETON PROTEIN; FODRIN; GENE PRODUCT; PROTEINASE;

ENZYME ACTIVITY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MEDICAL RESEARCH; MISSENSE MUTATION; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; REVIEW;

ANIMALS; CALPAIN; CARRIER PROTEINS; COS CELLS; HUMANS; HYDROLYSIS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUTATION, MISSENSE;

EID: 0033431885     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(99)00018-3     Document Type: Review

References (36)

1. Anderson L.V., Davison K., Moss J.A.et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol. 153:1998;1169-1179.
2. Baghdiguian S., Martin M., Richard I.et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 5:1999;503-511.
3. Beckmann J.S., Bushby K.M. Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol. 9:1996;389-393.
4. Brook J.D., McCurrach M.E., Harley H.G.et al. Molecular basis of myotonic dystrophy. expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member Cell. 68:1992;799-808.
5. Bushby K.M. Making sense of the limb-girdle muscular dystrophies. Brain. 122:1999;1403-1420.
6. Bushby K.M., Beckmann J.S. The limb-girdle muscular dystrophies - proposal for a new nomenclature. Neuromuscul Disord. 5:1995;337-343.
7. Campbell K.P. Three muscular dystrophies. loss of cytoskeleton-extracellular matrix linkage Cell. 80:1995;675-679.
8. Dear N., Matena K., Vingron M.et al. A new subfamily of vertebrate calpains lacking a calmodulin-like domain. implications for calpain regulation and evolution Genomics. 45:1997;175-184.
9. Fardeau M., Hillaire D., Mignard C.et al. Juvenile limb-girdle muscular dystrophy. clinical, histopathological, and genetic data from a small community living in the Reunion Island Brain. 119:1996;295-308.
10. Fougerousse F., Durand M., Suel L.et al. Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics. 48:1998;145-156.
11. Goldstein M.A., Michael L.H., Schroeter J.P.et al. Two structural states of Z-bands in cardiac muscle. Am J Physiol. 256(2 Pt. 2):1989;H552-H559.
12. Gregorio C.C., Granzier H., Sorimachi H.et al. Muscle assembly. a titanic achievement? Curr Opin Cell Biol. 11:1999;18-25.
13. Herasse M., Ono Y., Fougerousse F.et al. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and post-transcriptional events. Mol Cell Biol. 19:1999;4047-4055.
14. Hoffman E.P., Brown R.H. Jr., Kunkel L.M. Dystrophin. the protein product of the Duchenne muscular dystrophy locus Cell. 51:1987;919-928.
15. Lee H.J., Sorimachi H., Jeong S.Y.et al. Molecular cloning and characterization of a novel tissue-specific calpain predominantly expressed in the digestive tract. Biol Chem. 379:1998;175-183.
16. Ma H., Fukiage C., Azuma M.et al. Molecular cloning and expression of calpain Lp82 from rat lens. a splice variant of muscle p94 mRNA with insert regions deleted Invest Ophthalmol Vis Sci. 39:1997;454-461.
17. Maruyama K. Connectin/titin, giant elastic protein of muscle. FASEB J. 11:1997;341-345.
18. Mugita N., Kimura Y., Ogawa M.et al. Identification of a novel, tissue-specific calpain htra-3. a human homologue of the Caenorhabditis elegans sex determination gene Biochem Biophys Res Commun. 239:1997;845-850.
19. Ono Y., Shimada H., Sorimachi H.et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem. 273:1998;17,073-17,078.
20. Poussard S., Duvert M., Balcerzak D.et al. Evidence for implication of muscle-specific calpain (p94) in myofibrillar integrity. Cell Growth Differ. 7:1996;1461-1469.
21. Richard I., Broux O., Allamand V.et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
22. Siu B.L., Niimura H., Osborne J.A.et al. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation. 99:1999;1022-1026.
23. Sorimachi H., Imajoh-Ohmi S., Emori Y.et al. Molecular cloning of a novel mammalian calcium-dependent protease distinct form both m- and μ-types. J Biol Chem. 264:1989;20,106-20,111.
24. 2+-binding domain. J Biol Chem. 268:1993;19,476-19,482. a.
25. Sorimachi H., Toyama-Sorimachi N., Saido T.C.et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem. 268:1993;10,593-10,605. b.
26. Sorimachi H., Kinbara K., Kimura S.et al. Muscle-specific calpain, p94, responsible for limb-girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem. 270:1995;31,158-31,162.
27. Sorimachi H., Kimura S., Kinbara K.et al. Structure and physiological functions of ubiquitous and tissue-specific calpain species. Adv Biophys. 33:1996;101-122.
28. Sorimachi H., Freiburg A., Kolmerer B.et al. Tissue-specific expression and α-actinin binding properties of the Z-disc titin. implications for the nature of the vertebrate Z-disc J Mol Biol. 270:1997;688-695. a.
29. Sorimachi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem J. 328:1997;721-732. b.
30. Steff A.M., Carillo S., Pariat M.et al. Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts. Biochem J. 323:1997;685-692.
31. 2+-activated neutral protease and its inhibitors. in vitro effect on intact myofibrils Muscle Nerve. 3:1980;335-339.
32. Suzuki K., Sorimachi H., Yoshizawa T.et al. Calpain. novel family members, activation, and physiological function Biol Chem Hoppe-Seyler. 376:1995;523-529.
33. Takahashi K: 1990. Calpain substrate specificity. In Mellgren RL, Murachi T, eds. Intracellular Calcium-Dependent Proteolysis. Boca Raton, FL, CRC Press, pp. 55-74.
34. Tsujinaka T., Fujita J., Ebisui C.et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 97:1996;244-249.
35. Udd B., Haravuori H., Kalimo H.et al. Tibial muscular dystrophy - from clinical description to linkage on chromosome 2q31. Neuromuscul Disord. 8:1998;327-332.
36. Walowitz J.L., Bradley M.E., Chen S.et al. Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. J Biol Chem. 273:1998;6656-6661.